STEM-CELLBANKER® - GMP Grade
AMSBIOSTEM-CELLBANKER® is a chemically defined, animal-free freezing medium manufactured under GMP conditions- optimized for ES cell and iPS cell storage as well as other valuable cell types.
STEM-CELLBANKER® is a chemically defined, animal-free freezing medium manufactured under GMP conditions- optimized for ES cell and iPS cell storage as well as other valuable cell types.
First subjects recently administered immunizations in two studies of 20-valent pneumococcal conjugate vaccine candidate in infants; a pentavalent meningococcal vaccine candidate in adolescents; and a respiratory syncytial virus vaccine candidate in pregnant women
Promega and Incyte intend to work together in the future to develop the Promega OncoMate MSI Assay as a companion diagnostic
Study in metastatic triple-negative breast cancer presented at San Antonio Breast Cancer Symposium
Cyto-Mine Chroma is a multiplexing-capable, fully-automated single cell analysis platform that can encapsulate, analyze, sort, and dispense viable single cells
The Bio-Rad SARS-CoV-2 ddPCR Kit is a powerful diagnostic tool in the battle against COVID-19, with sensitivity and precision beyond that of qPCR assays.

The new computational infrastructure supports Roche’s vision of building an AI-accelerated healthcare organization
Nanoparticle Size and Zeta Potential Analyzer
Quality control of cell lines to improve validity in cell culture research.
The INTERCEPT Blood System, pathogen reduction system, a proactive approach to TTI risk reduction provides continued protection against TTIs through broad spectrum inactivation of viruses, bacteria, and parasites. INTERCEPT is approved as an alternative to gamma irradiation for prevention of transfusion-associated graft versus host disease (TA-GVHD) in platelet components.
Enhancing breast cancer diagnostics with precision, efficiency, and improved grading consistency for better patient outcomes
Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib
Thought leadership paper outlines the real impact of increasing transparency on the medical industry’s support of healthcare professionals and organizations